Pharmaceutical erythropoietin use in patients with cancer: Is it time to abandon ship or just drop anchor?

被引：12
作者：
Tefferi, Ayalew [1 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
来源：
MAYO CLINIC PROCEEDINGS | 2007年 / 82卷 / 11期
关键词：
RECOMBINANT-HUMAN-ERYTHROPOIETIN; CELL LUNG-CANCER; PLACEBO-CONTROLLED TRIAL; CHRONIC KIDNEY-DISEASE; QUALITY-OF-LIFE; EPOETIN-ALPHA; DOUBLE-BLIND; MYELODYSPLASTIC SYNDROMES; 1ST-LINE CHEMOTHERAPY; CERVICAL-CARCINOMA;
D O I：
10.4065/82.11.1316
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1316 / 1318
页数：3
相关论文
共 46 条
  • [1] Effect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer:: a meta-analysis
    Aapro, M.
    Coiffier, B.
    Dunst, J.
    Osterborg, A.
    Burger, H. U.
    [J]. BRITISH JOURNAL OF CANCER, 2006, 95 (11) : 1467 - 1473
  • [2] Autocrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cells
    Acs, G
    Chen, M
    Xu, XW
    Acs, P
    Verma, A
    Koch, CJ
    [J]. CANCER LETTERS, 2004, 214 (02) : 243 - 251
  • [3] Prognostic significance of erythropoietin expression in human endometrial carcinoma
    Acs, G
    Xu, XW
    Chu, C
    Acs, P
    Verma, A
    [J]. CANCER, 2004, 100 (11) : 2376 - 2386
  • [4] Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival
    Batra, S
    Perelman, N
    Luck, LR
    Shimada, H
    Malik, P
    [J]. LABORATORY INVESTIGATION, 2003, 83 (10) : 1477 - 1487
  • [5] Recombinant human erythropoietin is associated with increased overall survival in patients with multiple myeloma
    Baz, R.
    Walker, E.
    Choueiri, T. K.
    Abou Jawde, R.
    Brand, C.
    McGowan, B.
    Yiannaki, E.
    Andresen, S.
    Hussein, M. A.
    [J]. ACTA HAEMATOLOGICA, 2007, 117 (03) : 162 - 167
  • [6] Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells
    Beleslin-Cokic, BB
    Cokic, VP
    Yu, XB
    Weksler, BB
    Schechter, AN
    Noguchi, CT
    [J]. BLOOD, 2004, 104 (07) : 2073 - 2080
  • [7] The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
    Besarab, A
    Bolton, WK
    Browne, JK
    Egrie, JC
    Nissenson, AR
    Okamoto, DM
    Schwab, SJ
    Goodkin, DA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) : 584 - 590
  • [8] Recombinant human erythropoietin and overall survival in cancer patients: Results of a comprehensive meta-analysis
    Bohlius, J
    Langensiepen, S
    Schwarzer, G
    Seidenfeld, J
    Piper, M
    Bennett, C
    Engert, A
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (07): : 489 - 498
  • [9] Recombinant human erythropoietins and cancer patients: Updated meta-analysis of 57 studies including 9353 patients
    Bohlius, Julia
    Wilson, Jayne
    Seidenfeld, Jerome
    Piper, Margaret
    Schwarzer, Guido
    Sandercock, Josie
    Trelle, Sven
    Weingart, Olaf
    Bayliss, Sue
    Djulbegovic, Benjamin
    Bennett, Charles L.
    Langensiepen, Simon
    Hyde, Chris
    Engert, Andreas
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (10): : 708 - 714
  • [10] New agents that stimulate erythropoiesis
    Bunn, H. Franklin
    [J]. BLOOD, 2007, 109 (03) : 868 - 873
12345